Clinical trial
Weight Changes After Incretin-mimetics
Opening soon · Not applicable · 0 countries · Registry ID NCT06795360
What this study is about
The goal of this study is to identify people at risk of weight regain after stopping an injectable weight loss drug. The main question the investigators aim to answer is: Can weight regain be predicted by measuring circulating Agouti-related peptide, a small protein coming from the brain?
Basic eligibility
Full registry criteria
Treatments and study arms
discontinuation of weight loss medication
Participants will be studied right before their injectable weight loss medication runs out, and 3 months later
Primary outcomes
weight trajectories in the 3 months after treatment discontinuation
Circulating AgRP will be measured after an overnight fast and during a 3-hour mixed meal test, at baseline (while still on injectable weight loss drug) and 3 months later. The mixed meal will consist in a nutrtional shake consumed in 5 min.
Study locations
0 locations were listed when this page was built. The first 40 are shown.